• Our Services

    We offer best-in-class research and consulting services pertaining to the markets of all geographies. Our experienced team of business analysts and consultants has mastered fundamental and advanced market research in diverse industries.

  • Syndicated Research

    Syndicated research is the most cost-effective market research approach, which gives an analytical outlook of the competitive positioning, product positioning, and size estimation of the market at the micro level. Our off-the-shelf reports offer key market insights that industry stakeholders require to base their business strategy on. Our syndicated research services empower our clients to meet diverse market objectives.

  • Customized Research

    we also deliver customized research services to address specific needs of our clients. With a vast pool of adroit analysts who are proficient in market research, we take pride in tailoring our research services to meet our clients’ definite requirements and aid their business growth.

  • Consulting Services

    Businesses, today, need to adapt themselves to the changes that transpire in the market. Staying abreast of the market trends, therefore, becomes imperative for accomplishing business objectives.

  • Our Vision

    To be the most trusted partner in our clients' success endeavors

Showing posts with label Intermittent Claudication Therapeutics. Show all posts
Showing posts with label Intermittent Claudication Therapeutics. Show all posts

Intermittent Claudication Therapeutics - Pipeline Analysis, Clinical Trials & Results


Intermittent claudication refers to aching or squeezing pain in thighs, buttocks or feet during exercise, due to insufficient blood circulation resulting from peripheral arterial disease. The probability of developing peripheral arterial disease increases with the age.
Request to Get Free Sample Pages at:
                                                     https://www.pharmaproff.com/request-sample/1085

Smoking, high blood pressure, atherosclerosis, diabetes, and high cholesterol are some of the risk factors associated with the development of peripheral arterial disease, resulting in intermittent claudication. Intermittent claudication is detected by the pulse and blood pressure in legs and by arteriogram. The standard treatments available for intermittent claudication are angioplasty and surgery.

Request to Get Free Sample Pages at:  

 Pluristem Ltd. is in the process of developing PLX-PAD for the treatment of intermittent claudication associated with peripheral arterial disease. Some of the companies involved in intermittent claudication pipeline include Kowa Company Ltd., and Nissan Chemical Industries Ltd. Among others.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Share:

Profile

Popular Posts

APSense

Labels

Linkedin Profile

APSense

Business Network

Recent Posts

Research Pages